12,437 Shares in Helmerich & Payne, Inc. (NYSE:HP) Bought by Cerebellum GP LLC

Share on StockTwits

Cerebellum GP LLC acquired a new position in shares of Helmerich & Payne, Inc. (NYSE:HP) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 12,437 shares of the oil and gas company’s stock, valued at approximately $565,000.

Other hedge funds have also made changes to their positions in the company. Parallel Advisors LLC lifted its position in shares of Helmerich & Payne by 59.3% during the 3rd quarter. Parallel Advisors LLC now owns 1,117 shares of the oil and gas company’s stock worth $45,000 after buying an additional 416 shares during the last quarter. NuWave Investment Management LLC increased its holdings in Helmerich & Payne by 792.3% in the 3rd quarter. NuWave Investment Management LLC now owns 1,276 shares of the oil and gas company’s stock worth $49,000 after purchasing an additional 1,133 shares in the last quarter. Point72 Hong Kong Ltd increased its holdings in Helmerich & Payne by 43.4% in the 2nd quarter. Point72 Hong Kong Ltd now owns 1,361 shares of the oil and gas company’s stock worth $69,000 after purchasing an additional 412 shares in the last quarter. CSat Investment Advisory L.P. increased its holdings in Helmerich & Payne by 47.6% in the 2nd quarter. CSat Investment Advisory L.P. now owns 1,389 shares of the oil and gas company’s stock worth $71,000 after purchasing an additional 448 shares in the last quarter. Finally, Synovus Financial Corp increased its holdings in Helmerich & Payne by 682.3% in the 3rd quarter. Synovus Financial Corp now owns 2,425 shares of the oil and gas company’s stock worth $98,000 after purchasing an additional 2,115 shares in the last quarter. Institutional investors and hedge funds own 90.42% of the company’s stock.

In related news, CEO John W. Lindsay sold 45,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 20th. The stock was sold at an average price of $38.61, for a total transaction of $1,737,450.00. Following the completion of the sale, the chief executive officer now owns 318,441 shares of the company’s stock, valued at $12,295,007.01. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP John R. Bell sold 9,000 shares of the firm’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $38.67, for a total value of $348,030.00. Following the sale, the vice president now directly owns 81,426 shares of the company’s stock, valued at approximately $3,148,743.42. The disclosure for this sale can be found here. Corporate insiders own 4.17% of the company’s stock.

A number of equities analysts have issued reports on HP shares. B. Riley lowered their target price on Helmerich & Payne from $63.00 to $47.00 and set a “buy” rating for the company in a report on Friday, December 6th. Evercore ISI raised Helmerich & Payne from an “in-line” rating to an “outperform” rating and set a $24.00 target price for the company in a report on Monday, November 11th. ValuEngine raised Helmerich & Payne from a “sell” rating to a “hold” rating in a report on Wednesday, October 2nd. Wells Fargo & Co reaffirmed a “sell” rating on shares of Helmerich & Payne in a report on Monday, December 9th. Finally, Citigroup cut Helmerich & Payne from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $50.00 to $43.00 in a report on Monday, September 30th. Five investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and nine have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $47.95.

Shares of HP stock opened at $46.06 on Thursday. The stock has a market cap of $5.04 billion, a price-to-earnings ratio of 26.32, a PEG ratio of 8.84 and a beta of 1.68. The stock has a 50-day moving average of $43.43 and a 200-day moving average of $42.57. The company has a current ratio of 2.72, a quick ratio of 2.35 and a debt-to-equity ratio of 0.12. Helmerich & Payne, Inc. has a 1-year low of $35.74 and a 1-year high of $64.80.

Helmerich & Payne (NYSE:HP) last issued its quarterly earnings results on Thursday, November 14th. The oil and gas company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.14. The company had revenue of $649.10 million during the quarter, compared to analysts’ expectations of $650.92 million. Helmerich & Payne had a positive return on equity of 4.68% and a negative net margin of 1.20%. The business’s quarterly revenue was down 6.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.19 earnings per share. Sell-side analysts forecast that Helmerich & Payne, Inc. will post 0.33 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, March 2nd. Stockholders of record on Monday, February 10th will be paid a $0.71 dividend. The ex-dividend date is Friday, February 7th. This represents a $2.84 annualized dividend and a dividend yield of 6.17%. Helmerich & Payne’s payout ratio is 162.29%.

Helmerich & Payne Profile

Founded in 1920, Helmerich & Payne, Inc (H&P) (NYSE: HP) is committed to delivering industry leading levels of drilling productivity and reliability. H&P operates with the highest level of integrity, safety and innovation to deliver superior results for its customers and returns for shareholders.

See Also: What is the Coverage Ratio?

Want to see what other hedge funds are holding HP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Helmerich & Payne, Inc. (NYSE:HP).

Institutional Ownership by Quarter for Helmerich & Payne (NYSE:HP)

Receive News & Ratings for Helmerich & Payne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helmerich & Payne and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.